Expert Care for Fallopian Tube Cancer

Fallopian Tube Cancer: Symptoms, Causes, Diagnosis, and Treatment | AIROC Hospitals

About Fallopian Tube Cancer – Overview and Types

Fallopian tube cancer is a rare form of cancer that develops in the fallopian tubes, the two slender tubes that connect the ovaries to the uterus. It is closely related to ovarian and primary peritoneal cancer, and current research suggests that many high-grade ovarian cancers actually originate in the fallopian tubes. At AIROC Hospitals, our gynecologic oncology specialists bring focused expertise to diagnosing and treating this uncommon but serious cancer.

Because fallopian tube cancer is rare and its early symptoms can be subtle or easily mistaken for other conditions, it is often diagnosed at a more advanced stage. Our team at AIROC Hospitals emphasizes thorough evaluation and a coordinated treatment approach to give patients the best possible outcome.

Types of Fallopian Tube Cancer

Fallopian tube cancer is classified based on the type of cell in which it originates:

• Serous Carcinoma – The most common type, arising from the cells lining the fallopian tube and closely resembling high-grade serous ovarian cancer.
• Endometrioid Carcinoma – Develops from gland-like cells and tends to behave similarly to endometrial cancer.
• Clear Cell Carcinoma – A less common but more aggressive subtype.
• Transitional Cell Carcinoma – A rare type arising from transitional cells within the tube.
• Sarcoma of the Fallopian Tube – An extremely rare form arising from the connective tissue of the tube rather than its lining.

Because of its close relationship to ovarian cancer, accurate identification of the tumor's origin and type is essential, and our specialists at AIROC Hospitals ensure a precise pathological diagnosis to guide treatment.

 

Symptoms and Causes

Common Symptoms of Fallopian Tube Cancer

Symptoms of fallopian tube cancer are often vague in the early stages, which makes awareness particularly important:

• Abnormal vaginal bleeding or discharge, sometimes watery or blood-tinged
• Pelvic or lower abdominal pain or pressure
• A palpable mass or swelling in the pelvic area
• Bloating or a feeling of fullness
• Changes in bowel or bladder habits
• Unexplained weight loss
• Fatigue

Because these symptoms overlap with many other gynecologic conditions, persistent or unusual symptoms should always be evaluated by a specialist rather than dismissed.

Causes and Risk Factors

The exact cause of fallopian tube cancer is not fully understood, but several risk factors have been identified:

• BRCA1 and BRCA2 Gene Mutations: Inherited mutations in these genes significantly increase the risk of fallopian tube, ovarian, and breast cancers.
• Family History: A family history of ovarian, fallopian tube, or breast cancer raises individual risk.
• Age: Most commonly diagnosed in women over the age of 50, particularly after menopause.
• Personal History of Breast Cancer: Women previously diagnosed with breast cancer, especially with a genetic predisposition, may have an elevated risk.
• Reproductive History: Never having been pregnant may be associated with a slightly increased risk.
• Hereditary Cancer Syndromes: Conditions such as Lynch syndrome can also increase susceptibility.

Because of the strong genetic link, individuals with a known family history or BRCA mutation are encouraged to discuss risk-reduction strategies and screening options with our specialists at AIROC Hospitals.

 

Diagnosis and Treatment

How Fallopian Tube Cancer Is Diagnosed

At AIROC Hospitals, we use a combination of clinical evaluation, imaging, and laboratory testing to diagnose fallopian tube cancer:

• Pelvic Examination: An initial assessment to check for masses or abnormalities in the pelvic region.
• Transvaginal Ultrasound: Helps visualize the fallopian tubes, ovaries, and uterus for abnormal growths.
• CA-125 Blood Test: A tumor marker that may be elevated in fallopian tube and ovarian cancers, used to support diagnosis and monitor treatment response.
• CT, MRI, or PET Scans: Used to determine the size of the tumor and check for spread to nearby organs or lymph nodes.
• Biopsy or Surgical Exploration: Since fallopian tube cancer is often diagnosed during surgery for a suspected ovarian mass, tissue samples are examined to confirm the diagnosis and origin.
• Genetic Testing: Recommended to check for BRCA1/BRCA2 mutations, which can guide both treatment decisions and family screening.

Treatment Options at AIROC Hospitals

Treatment for fallopian tube cancer is closely aligned with ovarian cancer protocols and is tailored to the stage and extent of disease:

• Surgery: The primary treatment, typically involving removal of the uterus, ovaries, fallopian tubes, and nearby lymph nodes (staging surgery), along with as much visible tumor as possible (debulking).
• Chemotherapy: Commonly used after surgery to eliminate remaining cancer cells, and sometimes given before surgery to shrink larger tumors.
• Targeted Therapy: Includes PARP inhibitors, which can be particularly effective in patients with BRCA mutations.
• Hormone Therapy: May be considered for certain hormone-receptor-positive tumors.
• Maintenance Therapy: Ongoing targeted or hormonal treatment after initial therapy to help delay recurrence in appropriate candidates.

Our multidisciplinary team at AIROC Hospitals — including gynecologic oncologists, genetic counselors, and medical oncologists — works together to provide comprehensive, individualized care for women with fallopian tube cancer.

 

Prevention and Risk Factors

Because fallopian tube cancer is rare and often linked to genetic factors, prevention focuses primarily on risk awareness and reduction strategies:

• Genetic Counseling and Testing: Women with a family history of ovarian, fallopian tube, or breast cancer should consider genetic counseling to assess BRCA1/BRCA2 status.
• Risk-Reducing Surgery: For women with confirmed BRCA mutations, preventive removal of the fallopian tubes and ovaries may significantly lower risk once childbearing is complete.
• Regular Gynecologic Care: Routine check-ups can help identify pelvic abnormalities early, even though no standard screening test exists for fallopian tube cancer.
• Awareness of Family History: Understanding and sharing family cancer history with your doctor helps guide personalized risk assessment.
• Prompt Evaluation of Symptoms: Persistent pelvic pain, abnormal bleeding, or bloating should be assessed by a specialist without delay.

At AIROC Hospitals, we encourage women — particularly those with a family history of ovarian or breast cancer — to seek genetic counseling and maintain regular gynecologic care, as early detection and risk awareness play a vital role in improving outcomes for fallopian tube cancer.

 

This content is intended for informational purposes only and does not substitute professional medical advice. Please consult a specialist at AIROC Hospitals for personalized diagnosis and treatment recommendations.